|
Tuesday, February 14 — 8:00 AM — International South
Click on the numbers in parentheses to display abstracts.
Section G1 - NEUROPATHOLOGY
Chaired by: Arie Perry and Gregory N. Fuller
| 8:00 |
Activation of C-Jun NH2-terminal Kinases (JNKs) Correlates with the Histologic Grades and EGF Receptor Expression in Diffuse Gliomas
(1328)
SA May, H Wang, GN Fuller, TT Wu, A Rashid, SR Hamilton, H Wang - The University of Texas MD Anderson Cancer Center
|
| 8:15 |
Increased Annexin A1 Expression in High-Grade Diffuse Gliomas: A Potential Prognostic Marker
(1325)
AE Gullet, GN Fuller, Y Wu, JM Bruner, CT Albarracin - UT MD Anderson Cancer Center, Houston, TX
|
| 8:30 |
IGFBP2-Associated Diffuse Glioma Initiation and Progression Demonstrated in the RCAS-tva Mouse Model System
(1323)
SM Dunlap, JC Celestino, EC Holland, W Zhang, GN Fuller - The University of Texas MD Anderson Cancer Center, Houston, TX; Memorial Sloan Kettering Cancer Center, New York, NY
|
| 8:45 |
Identification Of Novel Proteins In Brain Tissue From Patients With Creutzfeldt-Jakob Disease Using A Functional Proteomics Approach: Implications for Prion Disease Pathogenesis
(1324)
BE Etchebarne, RJ Castellani - Michigan State University, East Lansing, MI; University of Maryland, Baltimore, MD
|
| 9:00 |
CADASIL: New Evidence of Vascular Degeneration
(1318)
R Bagdasaryan, T Brennan-Krohn, S Salloway, M Dong, SM de la Monte - Rhode Island Hospital, Butler Hospital, Brown University, Providence, RI
|
| 9:15 |
Evaluation Of NF2 Gene Deletion In Sporadic Schwannomas, Meningiomas And Ependymomas By Chromogenic In Situ Hydridization
(1319)
MD Begnami, M Palau, E Rushing, M Santi, M Quezado - National Institute of Health, Bethesda, MD; Armed Forces Institute of Pathology, Childrens Hospital, Washington, DC
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
|
|
|
